Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms Health Condition 2: N403- Nodular prostate with lower urinary tract symptoms Health Condition 3: C61- Malignant neoplasm of prostate
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Indian Council of Medical Research (ICMR)
Eligibility
Inclusion criteria
Inclusion criteria: Men above 40 years of age presenting with lower urinary tract symptoms and PSA values 4-10 ng/ml would be recruited as study subjects. Participants willing to provide a written informed consent will be included in the study
Exclusion criteria
Exclusion criteria: Men with any urological malignancy other than prostate, those who had previous prostatic surgery or pelvic radiotherapy or complications of urinary obstruction due to bladder stones, renal failure, and recurrent urinary tract infection will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differentiate between benign prostate hyperplasia and prostate cancerTimepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Using an adjunct marker like PSP94 along with PSA will aid clinicians in better decision making for referring patients for prostate biopsies & will also be cost-effective option as compared to other diagnostic tests like PHI, 4K score & multiparametric MRITimepoint: Baseline | — |
Countries
India
Contacts
Public ContactDr Dhanashree Jagtap
ICMR-National Institute for Research in Reproductive and Child Health (ICMR-NIRRCH)
Outcome results
None listed